$NSLR

Neostellar Capital Q3 2026 Earnings Preview (NSLR:NASDAQ)

Neostellar Capital (NSLR) will report Q3 2026 earnings on November 2. Analysts expect -$0.15 EPS and $0.28M revenue. Estimates have seen downward revisions. The company recently outlined a $20M note with a 6.5% interest rate and a $230M equity trigger.

Original reporting
Published Nov 2, 2026, 10:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NSLR
Neutral
medium confidence
Mentioned
$NSLR
Relevance
4/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$NSLRNeutralLow
01

Why it matters

The preview offers limited actionable insight; traders may watch the actual release for price moves.

02

Market read

Earnings preview with consensus estimates; low immediate trading relevance until actual results are released.

03

What to watch

Potential hidden guidance or operational updates not captured in consensus estimates.

Relevance 4/10Novelty 2/10Timing: after market close on November 2

Background

Neostellar Capital is a micro‑cap listed on NASDAQ, scheduled to report Q3 2026 earnings after market close.

Company-level read

Ticker impact

$NSLRNeutralMedium confidence
Context

The article previews Neostellar Capital's Q3 2026 earnings, providing consensus EPS and revenue estimates ahead of the scheduled release.

Expected impact

likely downside as the market may price in a miss versus the -$0.15 EPS consensus

Evidence & confidence

No new earnings numbers are disclosed; only consensus forecasts are mentioned, limiting actionable insight.

Market effects

Provides a brief outlook for the financial services sector but no sector-wide impact.

Limited to US investors tracking NASDAQ-listed microcaps.

Minimal; the story is company‑specific without broader macro implications.

Counterpoint

If the company surprises positively, the stock could rally despite low expectations.

Key entities

  • Neostellar Capital

    NASDAQ‑listed micro‑cap preparing to release Q3 earnings.

Related articles

$NSLRMed

Neostellar Capital Q3 Earnings Call Highlights

Neostellar Capital (NSLR) reported Q3 investments in AI-related companies, including OpenAI, ClickHouse, and TensorWave. OpenAI's valuation was noted at $852B, with $50B annualized revenue. WHOOP's valuation was adjusted, and Neostellar plans to monetize part of its investment. The company exited several investments, including Learneo and Aventine Property Group, with realized losses. Neostellar ended the quarter with $42.2M in liquid assets and plans to repay debt by year-end.

$NSLRMed

Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results Net Asset Value of $12.64 Per Share as of September 30, 2026 Board of Directors Approves Extension of Share Repurchase Program NEW YORK, NY, November 3, 2026 (GLOBE NEWSWIRE) – Neostellar Capital C

$NSLRLow

Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update Net Asset Value Expected to be $12.25 to $12.75 Per Share NEW YORK, NY, October 5, 2026 (GLOBE NEWSWIRE) – Neostellar Capital Corp. (“Neostellar Capital”, the “Company”, “we

$NSLRMed

Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results An Affiliate of Magnetar Invested $20.0 Million in Neostellar Through a Redeemable Promissory Note Subsequent to Quarter-End Net Asset Value of $13.44 Per Share as of June 30, 2026 NEW YORK, NY, A

$SOPHMed

Sophia Genetics SA (SOPH) (Q3 2026) Earnings Call Highlights: Revenue Surges 25% with Strong

Sophia Genetics SA (SOPH) reported a 25% revenue surge in Q3 2026. CEO Ross Muken expects continued growth in 2027, driven by strong product momentum and a high backlog of customers. The company is investing in medical affairs to drive adoption and has secured notable biopharma collaborations, including with AstraZeneca. CFO George Cardoza emphasized profitability commitments and conservative guidance.

$ONHighAI 8/10

Onsemi delays auto restocking as AI sales jump 175%

Onsemi (ON) reported Q3 revenue of $1.72B, up 11% YoY, with AI data center revenue jumping 175% to $180M. The company is prioritizing AI and industrial chip supply, delaying some automotive restocking orders. Onsemi acquired Ferric for $600M to expand AI power management, raising its 2030 AI revenue target to over $3B. Shares rose 4.78% post-earnings.